Friday, November 21, 2014 10:42:44 AM
Congratulations on acquiring all of the shares. You're not the only one gathering up all you can, i have been doing the same. So have the insiders.
Take a look at all of the insider buys in 2014 by the company's directors.
Insider Transactions Reported - Last Two Years
Date Insider Shares Type Transaction Value*
Nov 7, 2014 BONIUK MILTON
Director
380,954 Indirect Purchase at $0 per share. N/A
Oct 1, 2014 BONIUK MILTON
Director
19,700 Direct Purchase at $3.10 per share. 61,070
Sep 30, 2014 BONIUK MILTON
Director
61,292 Direct Purchase at $3 - $3.16 per share. 189,0002
Sep 29, 2014 BONIUK MILTON
Director
15,841 Direct Purchase at $3.20 per share. 50,691
Sep 26, 2014 BONIUK MILTON
Director
3,167 Direct Purchase at $3.20 per share. 10,134
Aug 25, 2014 DIWAN ANIL
Officer
28,571 Indirect Purchase at $3.50 per share. 99,998
Aug 25, 2014 VYAS MEETA
Officer
21,429 Direct Purchase at $3.50 per share. 75,001
Jul 17, 2014 BONIUK MILTON
Director
28,572 Indirect Purchase at $3.50 per share. 100,002
Jul 17, 2014 BONIUK MILTON
Director
28,572 Direct Purchase at $3.50 per share. 100,002
Feb 20, 2014 DIWAN ANIL
Officer
15,000 Direct Purchase at $3.80 per share. 57,000
Feb 18, 2014 DIWAN ANIL
Officer
35,000 Direct Purchase at $3.30 - $3.62 per share. 121,0002
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM